Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
GHK-Cu (Scalp) vs Matrixyl (Palmitoyl Pentapeptide-4)
An educational, source-based comparison of GHK-Cu (Scalp) and Matrixyl (Palmitoyl Pentapeptide-4) — how each peptide works, what it's researched for, and what to know before going deeper.
Topical GHK-Cu applied to the scalp has been studied for its ability to enlarge hair follicles, prolong the anagen growth phase, and improve perifollicular vascularization through copper-dependent gene modulation.
- Follicle size and anagen phase
- Perifollicular angiogenesis
- Post-procedure scalp recovery (microneedling, transplant)
- • Topical use has a long cosmetic safety record.
- • Not a replacement for evidence-based therapies like minoxidil or finasteride.
Topical matrikine researched for collagen stimulation.
A signal peptide that mimics the procollagen-I fragment, stimulating fibroblasts to produce collagen, elastin, and glycosaminoglycans in topical cosmetic research.
- Dermal collagen synthesis
- Fine lines and skin firmness
- • Well tolerated in topical use.
- • Modest improvements; not equivalent to retinoids.
GHK-Cu (Scalp) vs Matrixyl (Palmitoyl Pentapeptide-4) — Key differences
- Class: GHK-Cu (Scalp) is classified as Hair · Follicle Health, while Matrixyl (Palmitoyl Pentapeptide-4) is Skin · Collagen.
- Primary research focus: GHK-Cu (Scalp) — follicle size and anagen phase; Matrixyl (Palmitoyl Pentapeptide-4) — dermal collagen synthesis.
- Tag: Hair vs Skin.